Comparer à la page en direct

MainContentStart

InstanceBeginEditable name="mainContent"

Notice of upcoming Monkeypox 2 Research Funding Opportunity

This funding opportunity is now available on

ResearchNet

.

CIHR would like to provide information to the research community on an upcoming funding opportunity to support interdisciplinary research on the evolving threat of Monkeypox. It is anticipated that the Monkeypox Interdisciplinary Research Funding Opportunity will be launched the week of December 19, 2022.

We are providing preliminary information to allow the research community to prepare and respond to an expedited process.

Research focus areas

This funding opportunity will support interdisciplinary Canadian research teams to generate timely and relevant research evidence across five broad priority areas:

Animal/ecological studies to understand zoonotic hosts, reservoirs and vectors and natural transmission/persistence dynamics, and zoonotic risks (approx. $4M);

Public health research (e.g.: epidemiological studies) focused on transmission pathways of the virus and disease pathogenesis including differences in viral clades (strains) (approx. $2M);

Public health risk intervention/management (approx.$2M); and,

Social and behavioural science studies including combatting mis and dis-information and supporting harm reduction research for high-risk populations (approx. $2M).

Research at the intersection of monkeypox and Sexually Transmitted and Blood-Borne Infections (STBBI), including HIV ($1M, funding from the CIHR HIV/AIDS and STBBI Research Initiative).

This investment will support the integration of research with policy and clinical and public health practice. This will be critical for improving the understanding of the virus, help to better monitor the situation, predict and identify current and future outbreaks, support the development of more effective treatments and prevention and control guidelines, and inform national and global decision-making and public health action. Finally, this investment will contribute to building capacity in Canada to undertake research on viral zoonotic infections of domestic or global origins.

Availability of Funds

The total amount available for this funding opportunity is approximately $11M. The Government of Canada's financial contributions are subject to availability of funds. This amount may increase if additional funding partners participate. Should the Government of Canada funding levels not be available or are decreased due to unforeseen circumstances, the Government of Canada reserves the right to

reduce, defer or suspend financial contributions

to grants received as a result of this funding opportunity.

Anticipated timelines

These dates are estimates and subject to change.

This funding opportunity is anticipated to launch in the week of December 19, 2022. As this will be a rapid response funding opportunity, it is anticipated that registrations will be due within a few weeks of the launch and that the notice of decision and funding will be made available within several months of the launch.

Please also note

Given the urgency of this funding competition, recruitment for peer reviewers will begin immediately. If you are interested and available to volunteer as a peer reviewer, please reach out to CIHR immediately at

pdd-crpphe-cep-crppus@cihr-irsc.gc.ca

.

We thank applicants and peer reviewers in advance for their flexibility and understanding with respect to the need for this expedited process.

Contact Information

For general inquiries please contact:

CIHR Contact Centre

Telephone: 613-954-1968

Toll Free: 1-888-603-4178

support-soutien@cihr-irsc.gc.ca

Disclaimer

The information contained herein is anticipatory only and does not represent an official funding commitment by the Canadian Institutes of Health Research. Accordingly, the information contained herein may differ from the official funding opportunity, if and when, that will be published on

ResearchNet

.

InstanceEndEditable

Date modified:

InstanceBeginEditable name="dateModified"

2022-12-20

InstanceEndEditable